FDA Inspection
Viva Pharmaceutical IncViva Pharmaceutical Inc – FDA Inspection, Oct 25, 2024
Record Details
This FDA Inspection record concerns Viva Pharmaceutical Inc, with an inspection on October 25, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 89df56cc-5b85-46cf-9921-307a3be87e5c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1252505
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Viva Pharmaceutical Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 1, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Viva Pharmaceutical Inc
- FDA Inspection 1115290 - 2020-01-10
- FDA Inspection 1032526 - 2017-12-01
- FDA Inspection 948706 - 2015-10-23
- FDA Inspection 750132 - 2011-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.